NCT01206530 FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01183663 Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) Status COMPLETED Phase PHASE1
NCT01164215 Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy Status COMPLETED Phase PHASE1
NCT01150045 Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Status COMPLETED Phase PHASE3
NCT01121848 Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer Status COMPLETED Phase PHASE3
NCT01102686 Pyrimethamine as a Treatment for Late-Onset GM2-gangliosidosis (Tay-Sachs and Sandhoff Disease) Status COMPLETED Phase PHASE1/PHASE2
NCT01077739 A Study of Avastin (Bevacizumab) With XELOX or FOLFOX in Patients With Metastatic Colorectal Cancer and Disease Progression Under First-line FOLFIRI and Avastin Status COMPLETED Phase PHASE2
NCT01060007 Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer Status COMPLETED Phase PHASE2
NCT01046864 Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI) Status COMPLETED Phase PHASE1
NCT01014767 Intercontinental Multidisciplinary Registry and Treatment Optimization Study for Choroid Plexus Tumors Status TERMINATED Phase PHASE3
NCT01013805 Preoperative Radiotherapy and Chemotherapy in Patients With Locally Advanced Rectal Cancer Status COMPLETED Phase PHASE2
NCT00941655 Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial Status COMPLETED Phase PHASE3
NCT00941499 Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab Status COMPLETED Phase PHASE1
NCT00940303 OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00932438 Drug-Eluting Bead, Irinotecan (DEBIRI) Therapy of Liver Metastasis From Colon Cancer With Systemic Fluorouracil, Oxaliplatin, Leucovorin and Bevacizumab Status COMPLETED Phase PHASE1/PHASE2
NCT00889343 Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer Status TERMINATED Phase PHASE2
NCT00878254 Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00831181 Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal Cancer Status COMPLETED Phase PHASE2
NCT00803647 A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver Status COMPLETED Phase PHASE2
NCT00778102 A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer. Status COMPLETED Phase PHASE2